Skip to Content

Join the 'Bladder Cancer' group to help and get support from people like you.

Bladder Cancer News

Related terms: Cancer, Bladder

Could Certain Hair Dyes, Relaxers Raise Breast Cancer Risk?

Posted 7 days ago by Drugs.com

TUESDAY, June 20, 2017 – The safety of hair products has been debated for years. Now, new research suggests that black women who use dark hair dyes face a higher risk of breast cancer, while chemical relaxers and straighteners boost the odds in white women. The findings stem from a study of more than 4,000 women. Use of dark brown or black hair dyes by black women was tied to a 51 percent greater risk of breast cancer. And whites who used hair relaxers had 74 percent higher odds. But while the study found a possible link between the hair products and breast cancer risk, it did not prove a connection. "Our findings do not suggest that simply using hair dyes, relaxers or both will cause a woman to get breast cancer," cautioned study lead author Adana Llanos. "The reality is that we regularly encounter a variety of harmful exposures, which we have no control over," said Llanos, an ... Read more

Related support groups: Breast Cancer, Poisoning, Bladder Cancer, Breast Cancer, Prevention

'Couch Potatoes' May Face Higher Risk of Kidney, Bladder Cancers

Posted 12 days ago by Drugs.com

THURSDAY, June 15, 2017 – Add greater risk of kidney and bladder cancer to the long list of why a lifetime of sitting on the sofa isn't good for your health, a new study suggests. Specifically, lifetime recreational inactivity was associated with a 73 percent increased risk of bladder cancer and a 77 percent increased risk of kidney cancer. The findings add to growing evidence that inactivity may be a significant risk factor for cancer, the researchers said. "We hope that findings like ours will motivate inactive people to engage in some form of physical activity," said study senior author Kirsten Moysich. She is a professor of oncology at Roswell Park Cancer Institute in Buffalo, N.Y. "You don't have to run marathons to reduce your cancer risk, but you have to do something – even small adjustments like taking the stairs instead of the elevator, walking around the block a couple of ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Bladder Cancer, Solid Tumors, Urothelial Carcinoma

E-Cigarettes Linked to Bladder Cancer Risk

Posted 15 May 2017 by Drugs.com

MONDAY, May 15, 2017 – Although many people think "vaping" is safer than smoking, research suggests that both e-cigarettes and traditional cigarettes are tied to an increased risk for bladder cancer. "We've known traditional smoking raises bladder cancer risk, and given the surge in popularity of e-cigarettes, it's imperative we uncover any potential links" between e-cigarettes and bladder cancer, Dr. Sam Chang said in an American Urological Association news release. Chang is a professor of urologic surgery at Vanderbilt-Ingram Cancer Center in Nashville. Most inhaled nicotine is excreted in the urine. For the study, the researchers compared the urine of people who use e-cigarettes with that of nonsmokers. The investigators looked for five chemicals known to cause bladder cancer and may be found in e-cigarette liquid. Ninety-two percent of e-cigarette users tested positive for two of ... Read more

Related support groups: Smoking, Smoking Cessation, Nicotine, Nicorette, Nicoderm CQ, Nicotrol Inhaler, Bladder Cancer, Commit, Habitrol, Nicotrol TD, Nicorelief, Nicorette DS, Urothelial Carcinoma, Nicotrol NS, ProStep

AstraZeneca’s Imfinzi (durvalumab) Receives FDA Accelerated Approval for Previously Treated Patients with Advanced Bladder Cancer

Posted 1 May 2017 by Drugs.com

May 1, 2017 – AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to Imfinzi (durvalumab). Imfinzi is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy, or whose disease has progressed within 12 months of receiving platinum-containing chemotherapy before (neoadjuvant) or after (adjuvant) surgery. Imfinzi is approved under the FDA’s accelerated approval pathway, based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. Pascal Soriot, Chief Executive Officer of AstraZeneca, said: “We are excited to off ... Read more

Related support groups: Bladder Cancer, Durvalumab, Urothelial Carcinoma, Imfinzi

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Osteosarcoma, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Endometrial Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Breast Cancer - Adjuvant, Melanoma - Metastatic

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Testicular Cancer, Breast Cancer - Palliative, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma

Posted 10 Feb 2017 by Drugs.com

PRINCETON, N.J.--(BUSINESS WIRE)-- February 2, 2017 – Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has approved Opdivo injection, for intravenous use for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.1 The recommended dose for mUC is 240 mg administered as an intravenous infusion over 60 minutes every two weeks until disease progression or ... Read more

Related support groups: Opdivo, Bladder Cancer, Nivolumab, Urothelial Carcinoma

Cancer Advances Demand Continual Funding, Specialists Say

Posted 29 Nov 2016 by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Bladder Cancer, Cervical Cancer, Head and Neck Cancer

Low Vitamin D Levels May Raise Bladder Cancer Risk: Study

Posted 8 Nov 2016 by Drugs.com

TUESDAY, Nov. 8, 2016 – Low vitamin D levels may increase the risk of bladder cancer, researchers report. Five of seven studies the researchers reviewed linked low vitamin D levels with an higher risk of bladder cancer. In experiments with the cells that line the bladder, the researchers found that the cells activate and respond to vitamin D. This, in turn, can stimulate an immune response, the study authors said. The finding is important because the immune system may help prevent cancer by identifying and destroying abnormal cells before they develop into cancer, according to lead author Rosemary Bland, an honorary associate professor at the University of Warwick in England. "More clinical studies are required to test this association, but our work suggests that low levels of vitamin D in the blood may prevent the cells within the bladder from stimulating an adequate response to ... Read more

Related support groups: Cancer, Vitamin D Deficiency, Bladder Cancer, Caltrate 600 with D, Calcium/Vitamin D, Citracal + D, Oysco 500 with D, Citracal Petites, Citracal Creamy Bites, Oyster Shell Calcium, Calcet, Calcium 600 D, Calcarb with D, Oyster Shell Calcium with Vitamin D, Calcio Del Mar, Dical-D, Oysco D with Calcium, Citracal Regular, Caltrate Colon Health, O-Cal-D

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

More Cancer Patients Gaining From Immune-Based Treatments

Posted 20 Sep 2016 by Drugs.com

TUESDAY, Sept. 20, 2016 – A leading cancer group says more Americans are benefiting from immunotherapy – a relatively new treatment approach that helps the immune system target and destroy cancer cells. "The promise of immunotherapy for cancer therapy has never been greater, and the opportunity to make significant progress in this critical area is real," said Dr. Nancy Davidson, president of the American Association for Cancer Research (AACR). The AACR issued the news on immunotherapy as part of its 2016 Cancer Progress Report. As the group explained, more types of cancer are being successfully treated with immunotherapy. This treatment involves adding new cancer-fighting cells to the body or adding new elements, such as antibodies and proteins, to help the immune system fight cancer. In August 2015, one class of immunotherapy drugs – called checkpoint inhibitors – was approved for ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Melanoma, Opdivo, Bladder Cancer, Melanoma - Metastatic, Keytruda, Head and Neck Cancer, Hodgkin's Lymphoma, Nivolumab, Tecentriq, Pembrolizumab, Atezolizumab

Women's Cancer Risk Rises With Years Spent Overweight

Posted 16 Aug 2016 by Drugs.com

TUESDAY, Aug. 16, 2016 – The longer a woman is overweight, the higher her risk of several cancers, researchers report. The study, which followed nearly 74,000 U.S. women, found that the longer a woman carried excess poundage, the greater her risk of breast, endometrial, colon and kidney cancers. "We've known for a long time that excess weight is important in cancer risk," said Susan Gapstur, vice president of epidemiology for the American Cancer Society. The cancer society says excess weight contributes to as many as 20 percent of all cancer deaths. "This study is interesting because it suggests that the number of years you spend being overweight also matters," said Gapstur, who was not involved in the research. And that, she said, should provide further incentive to avoid excess weight gain in the first place. Currently, about 7 out of 10 adults in the United States are overweight, ... Read more

Related support groups: Obesity, Cancer, Weight Loss, Breast Cancer, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Bladder Cancer, Urinary Tract Cancer

New Guidelines Issued for Cancer Patients' Post-Treatment Pain

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – More people are surviving cancer, but many are left with persistent pain after treatment. New guidelines from the American Society of Clinical Oncology (ASCO) recommend that doctors routinely screen for such pain. The guidelines also advise doctors to consider the use of non-traditional treatments for pain. These include hypnosis, meditation and medical marijuana where it's legal. ASCO also cautioned doctors to assess patients' risk for overuse of opioid painkillers. "Many oncologists and primary care physicians are not trained to recognize or treat long-term pain associated with cancer," guideline panel co-chair Judith Paice said in an ASCO news release. "This guideline will help clinicians identify pain early and develop comprehensive treatment plans, using a broad range of approaches," she said. Advances in cancer diagnosis and treatment have led to a record ... Read more

Related support groups: Pain, Suboxone, Oxycodone, Hydrocodone, Tramadol, Percocet, Methadone, Cancer, OxyContin, Vicodin, Norco, Fentanyl, Morphine, Codeine, Lortab, Chronic Pain, Tylenol, Opana, Ibuprofen, Naproxen

Cancer's Heavy Financial Burden

Posted 8 Jun 2016 by Drugs.com

WEDNESDAY, June 8, 2016 – Many cancer patients can't afford to see their doctor or take the medications they've been prescribed, a new study finds. And the problem will likely only get worse as the cost of cancer treatments continues to rise, the study authors said. "You can prescribe the best drug in the world, but if patients can't afford it and they can't get it, then it won't be effective," said study author Dr. Greg Knight. He is chief fellow with the University of North Carolina School of Medicine's division of hematology and oncology. "We saw a significant portion of patients in our study who were stretching their prescriptions or not coming to the doctor's office," Knight said in a university news release. The researchers reviewed survey results from nearly 2,000 patients at the N.C. Cancer Hospital in Chapel Hill, N.C. The participants were all 18 and older, and had been ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Gleevec, Colorectal Cancer, Votrient, Brain Tumor, Tarceva, Avastin, Melanoma, Skin Cancer, Nausea/Vomiting - Chemotherapy Induced, Tasigna, Ovarian Cancer, Endometrial Cancer, Sutent, Afinitor, Sprycel, Herceptin

Immune-Based Drug May Help Some With Advanced Bladder Cancer

Posted 5 Jun 2016 by Drugs.com

SUNDAY, June 5, 2016 – Patients with advanced bladder cancer can sometimes be too old or unhealthy to withstand standard chemotherapy. However, some may gain hope from a new drug that unleashes the immune system to attack tumor cells, researchers reported Sunday. Patients who responded to the drug Tecentriq (atezolizumab) had an average survival of nearly 15 months, about 5 to 6 months longer than people usually gain from platinum-based chemotherapy, said lead researcher Dr. Arjun Balar. The treatment didn't help everyone, however: Only about a quarter of patients responded to the drug. Still, any advance for this patient population is sorely needed, experts say. That's because about half of advanced bladder cancer patients cannot receive chemotherapy because they're too old to withstand chemo's toxic effects, explained Balar, who is assistant professor of medicine at NYU Langone ... Read more

Related support groups: Cancer, Bladder Cancer, Tecentriq, Atezolizumab

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Urothelial Carcinoma, Cancer

Related Drug Support Groups

methotrexate, cisplatin, cyclophosphamide, doxorubicin, Adriamycin, mitomycin, Tecentriq, Platinol, thiotepa, view more... Tepadina, Adriamycin PFS, Adriamycin RDF, atezolizumab, Mutamycin, Platinol-AQ, Thioplex